Company Description
Quarks may be the basic building blocks of matter, but it's a fundamental unit of biology -- genes -- that Quark Pharmaceuticals is interested in....
Key Quark Pharmaceuticals Financials
| Company Type | Private - NASDAQ (GM): QURK Proposed Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2006 Sales (mil.) | $4.3 |
| 2006 Employees | 63 |
More Quark Pharmaceuticals Financials (4 pages)
Latest Quark Pharmaceuticals Jobs jobs by Indeed
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Quark Pharmaceuticals's competition across multiple industries
Top Quark Pharmaceuticals Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Quark Pharmaceuticals Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Philip B. Simon | Network | E-mail |
| CEO | Daniel Zurr | Network | E-mail |
| COO | Rami Skaliter | Network | E-mail |
More Quark Pharmaceuticals Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Quark Pharmaceuticals News
- OLIGORIBONUCLEOTIDES AND METHODS OF USE THEREOF FOR TREATMENT OF CARDIOVASCULAR DISEASES [European Patents] (01 Jul 2008 13:09:00 EDT)
- BioWorld Today June 26, 2008 [BioWorld Today] (26 Jun 2008 00:01:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.